Rewalk Robotics Ltd (NASDAQ:RWLK) shares crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $3.83 and traded as high as $3.24. Rewalk Robotics shares last traded at $3.13, with a volume of 48,636 shares traded.

Several research firms have recently issued reports on RWLK. HC Wainwright raised shares of Rewalk Robotics from a “neutral” rating to a “buy” rating and increased their target price for the stock from $4.00 to $9.00 in a research note on Monday, June 17th. Zacks Investment Research lowered shares of Rewalk Robotics from a “hold” rating to a “sell” rating in a research note on Friday, August 16th. Finally, ValuEngine raised shares of Rewalk Robotics from a “hold” rating to a “buy” rating in a research note on Tuesday, July 2nd.

The stock has a market capitalization of $22.96 million, a PE ratio of -0.21 and a beta of 1.54. The stock’s 50 day moving average is $3.83 and its two-hundred day moving average is $2.87. The company has a debt-to-equity ratio of 0.33, a quick ratio of 3.09 and a current ratio of 3.41.

Rewalk Robotics (NASDAQ:RWLK) last issued its quarterly earnings results on Thursday, August 8th. The medical device company reported ($0.88) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.49) by ($0.39). The business had revenue of $0.88 million during the quarter, compared to analysts’ expectations of $2.48 million. Rewalk Robotics had a negative net margin of 320.80% and a negative return on equity of 452.23%. Equities research analysts expect that Rewalk Robotics Ltd will post -2.62 EPS for the current fiscal year.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Geode Capital Management LLC acquired a new position in Rewalk Robotics in the fourth quarter valued at $49,000. FNY Investment Advisers LLC increased its stake in Rewalk Robotics by 4,595.0% in the second quarter. FNY Investment Advisers LLC now owns 75,120 shares of the medical device company’s stock valued at $326,000 after purchasing an additional 73,520 shares during the period. Finally, Gabelli Funds LLC acquired a new position in Rewalk Robotics in the second quarter valued at $118,000. 34.47% of the stock is owned by hedge funds and other institutional investors.

About Rewalk Robotics (NASDAQ:RWLK)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe.

See Also: What are the benefits of a balanced fund?

Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.